Consideration of future consequences

Media Advisory: ICR Generative AI Webinar Series Part V

Retrieved on: 
Thursday, October 5, 2023
Technology, Finance, Public Relations, Investor Relations, Consulting, Marketing, Communications, Professional Services, Data Analytics, Environmental, Social and Governance (ESG), Artificial Intelligence, Narrative, ESG, Development, Risk management, Communes of Burundi, AI, Organization, Stakeholder engagement, Consideration of future consequences, Growth, Artificial intelligence, Capital market, Generative, Synthetic media, Part, ICR, Citigroup, Medical device, Customer service, Sales

ICR , a leading strategic communications and advisory firm, today announced details of the fifth edition of its generative AI webinar series , to explain how organizations can align their AI initiatives with investor demands to create long-term valuation and sustainable competitive advantages.

Key Points: 
  • ICR , a leading strategic communications and advisory firm, today announced details of the fifth edition of its generative AI webinar series , to explain how organizations can align their AI initiatives with investor demands to create long-term valuation and sustainable competitive advantages.
  • To register for “Capital Markets & Generative AI Strategy: Meeting Investor Expectations for AI-Driven Growth”, please visit: https://icr.swoogo.com/part_v/begin
    Capital Markets & Generative AI Strategy: Meeting Investor Expectations for AI-Driven Growth
    Throughout this session you will gain a deeper understanding of capital market expectations and how to position your generative AI strategy effectively to investors.
  • Key takeaways from the session include:
    Investor Perspectives on AI: The factors that capital markets consider when evaluating a company's generative AI strategy, including innovation, scalability, risk management, and ethical considerations.
  • Sirisha Kadamalakalva, Global Head of Artificial Intelligence, Citigroup
    Part I in the ICR Generative AI Webinar Series, Generative AI for C-Suite Leaders: A Primer on Strategy, Execution, and Stakeholder Engagement, is available for on-demand replay: https://icr.swoogo.com/Generative_AI
    Part II in the ICR Generative AI Webinar Series, Enhancing Customer Experience with Generative AI: Real-World Applications and Considerations, is available for on-demand replay: https://icr.swoogo.com/Generative_AI_two
    Part III in the ICR Generative AI Webinar Series, Strategic Communications in the AI Era: Understand How IR & PR Shape Your Company's AI Narrative, is available for on-demand replay: https://icr.swoogo.com/AI_III
    Part IV in the ICR Generative AI Webinar Series, Harnessing Generative AI for Sales & Marketing: Accelerating Efficient Growth Through GTM Innovation, is available for on-demand replay: https://icr.swoogo.com/AI_IV

A Closer Look Announces First-Party Research Report Unveiling Concerns and Considerations in the Senior Living Landscape

Retrieved on: 
Friday, August 11, 2023
A Closer Look (Steve Harley & Cockney Rebel album), Research report, Elder abuse, Friends, Research, Consideration of future consequences, A Closer Look, Assisted living, Risk, Senior living, Family, Caregiver, Safety, Tutoring, Management, Residential care, Nursing

ATLANTA, Aug. 11, 2023 /PRNewswire/ -- The senior living landscape is changing rapidly as the baby boomer generation shapes demographic trends. With 10,000 individuals turning 65 daily, seniors' share of the population is projected to exceed 20% by 2030. Understanding prospective residents' concerns is crucial due to the increasing demand for senior living options.

Key Points: 
  • Prominent customer experience research firm, A Closer Look, announced its first annual independent research report, "Exploring Concerns and Considerations in the Senior Living Landscape: A Closer Look's Independent Research."
  • A Closer Look's report reveals independent research findings on key concerns of individuals assessing senior living options.
  • The report outlines critical concerns expressed by respondents evaluating senior living options:
    Caregiver Support: Concerns about unsupportive caregivers and high turnover rates in assisted living communities caused discomfort and inconvenience.
  • "We are thrilled to unveil our inaugural comprehensive report on the senior living landscape," shared Chris Gillen, CEO of A Closer Look.

Ankura Releases 2022 Holiday Consumer Spending Survey Results

Retrieved on: 
Friday, October 28, 2022
Well, Retail, Risk, Senior, Family, Black Friday, Multimedia, Millennials, LLC, Create, Consideration of future consequences, NEW, Generation Z, Friends, Online shopping, Generation X

NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Ankura Consulting, LLC ("Ankura"), a leading global expert services and advisory firm, today published the results of its 2022 Holiday Consumer Spending Survey conducted by its Performance Improvement Practice. The survey, which polled 1,042 individuals across the United States, reveals key insights for retailers and the U.S. economy.

Key Points: 
  • Survey of More than 1,000 Consumers Across United States Reveals Key Insights and Considerations for Retailers and U.S. Economy
    NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Ankura Consulting, LLC ("Ankura"), a leading global expert services and advisory firm, today published the results of its 2022 Holiday Consumer Spending Survey conducted by its Performance Improvement Practice .
  • The survey, which polled 1,042 individuals across the United States, reveals key insights for retailers and the U.S. economy.
  • The survey identified several compelling takeaways about the changing consumer landscape and items of interest for the 2022 holiday shopping season, including:
    Approximately 66% of respondents plan to start their holiday shopping before Black Friday, the traditional kickoff for the holiday shopping season, with 25% stating that they've already started shopping as of mid-October and another 18% planning to start before the end of October.
  • Collaborative lateral thinking, hard-earned experience, expertise, and multidisciplinary capabilities drive results and Ankura is unrivaled in its ability to assist clients to Protect, Create and Recover Value.

FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions

Retrieved on: 
Tuesday, August 23, 2022
Chronic pain, Neuromodulation, Technology, NYSE, Pain, Program, Practice management software, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SCS, Time, Webbed toes, Longevity, Hyperreflexia, Sensation, Medical device, Food, Health, Abbott Laboratories, Physician, Randomized controlled trial, LinkedIn, Eucalyptus diversicolor, Quality of life, Deer, Poster, NANS, Clinical study design, ASPN, IFU, Patient, FDA, Parenteral nutrition, Twitter, Facebook, Gauge (instrument), Face, Spinal cord, BURST, Spinal cord stimulator, Consideration of future consequences, Wi-Fi, Life, Travel, Dentistry, Poultry, Brain

BurstDR therapy is Abbott's exclusive stimulation technology that delivers pulses or bursts of mild electrical energy to alter pain signals as they travel from the spinal cord to the brain.

Key Points: 
  • BurstDR therapy is Abbott's exclusive stimulation technology that delivers pulses or bursts of mild electrical energy to alter pain signals as they travel from the spinal cord to the brain.
  • Spinal Cord Stimulation for Chronic Pain Syndromes: A Review of Considerations in Practice Management.
  • Pain.
  • Utilizing intraoperative neuromonitoring to program multiple areas of Burst spinal cord stimulation for treatment of chronic pain.

Annals of Family Medicine: Emerging Research Documents Changing Landscape of Electronic Health Records in Primary Care

Retrieved on: 
Tuesday, July 26, 2022
Patient, Eye, Laika (EHR testing framework), Clinical, Documentation, Physician, Gaps, Use, Research, Community, Comprehensive, Electronic health record, Consideration of future consequences, Technology, Method, EHR, Communication, Editorial, Hypertension, ANN, Pharmaceutical industry, Medicine

ANN ARBOR, Mich., July 26, 2022 /PRNewswire/ -- In Use of the Electronic Health Record During Clinical Encounters: An Experience Survey, researchers conducted a survey to assess the impact of EHR practices on doctor-patient communication. Describing experiences with EHRs during clinical encounters, most clinicians reported less eye contact with patients (80%), listening less carefully (54%), and less focus (65%). Only one-third of clinicians thought patients saw EHR use as a positive experience. 

Key Points: 
  • In Communication Gaps Persist Between Primary Care and Specialist Physicians , researchers studied the impact of the Comprehensive Primary Care Plus (CPC+) model, which leverages EHRs to increase information sharing between primary care physicians and specialists about referred patients.
  • The authors found gaps in communication between primary care physicians and specialists have persisted over the last decade.
  • Through analyzing doctor-patient interactions, researchers found that the visualization tool promoted shared decision-making in hypertension management in the primary care setting.
  • In an accompanying editorial, Uplifting Primary Care Through the Electronic Health Record , Anthony Sunjaya notes that health care is rapidly becoming digital, helping to increase patient engagement in their own care, and improve primary care research.

Clinical Trial Design and Considerations for Below-the-Knee Interventions and Amputation Prevention, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, November 23, 2021
Patient, Review, Industry, Data management, Ulcer, Consideration of future consequences, Gangrene, Compliance, Amputation, Clinical trial, Doctor of Philosophy, Peripheral artery disease, MMI, Mortality, Food, PAD, Disease, Quality of life, Medical imaging

Chronic Limb Threatening Ischemia (CLTI) represents the most advanced clinical condition among the spectrum of patients with PAD.

Key Points: 
  • Chronic Limb Threatening Ischemia (CLTI) represents the most advanced clinical condition among the spectrum of patients with PAD.
  • During the second half of the webinar, a speaker from Medical Metrics, Inc. (MMI) will discuss the clinical trial infrastructure for this type of study from an independent core lab's perspective.
  • For more information, or to register for this event, visit Clinical Trial Design and Considerations for Below-the-Knee Interventions and Amputation Prevention.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.

New Research Shows Wireless Charging Could Accelerate Wide Scale Adoption of Electric Vehicles

Retrieved on: 
Wednesday, November 10, 2021
Environment, Technology, Mobile, Wireless, Automotive, General Automotive, Other Energy, Other Technology, Alternative Energy, Energy, Adoption, Climate change, Anxiety, Education, Ownership, EVS, WiTricity, Technology, Multimedia, NPS, Solution, Pew Research Center, GenX, Consideration of future consequences, Adult, Fireworks, Mobile phone

Respondents agree that wireless charging makes EV charging easier (72%) and more convenient (68%), and almost 2 in 3 (63%) say theyd like to see wireless charging in public EV charging stations.

Key Points: 
  • Respondents agree that wireless charging makes EV charging easier (72%) and more convenient (68%), and almost 2 in 3 (63%) say theyd like to see wireless charging in public EV charging stations.
  • The research shows consumers want wireless charging for their EVs, said WiTricity CEO Alex Gruzen.
  • Charging issues overall are the major barriers for EV adoption, and wireless charging can significantly help to reduce those barriers.
  • Advancements like dynamic charging of moving vehicles, and the charging of autonomous robots and vehicles without human intervention all depend on WiTricity technology.

Xtalks Announces Its Life Science Webinar Calendar for October 2021

Retrieved on: 
Friday, October 1, 2021
Therapy, Parallel, Food, XTalk, Patient, Woman, Breast cancer, Implementation, Consideration of future consequences, Benefit, LC-MS/MS, Development, Combination drug, Trust, Biomarker, Digital platform, Control, New product development, Sponsor, Ageing, Digital, Industry, Neurodegeneration, Role, Immunoassay, Medical imaging, Cryptocurrency, Medicine, Pharmaceutical industry

Access to all webinars is free, so be sure to register today to save your place!

Key Points: 
  • Access to all webinars is free, so be sure to register today to save your place!
  • Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)
  • Xtalks helps Life Science professionals stay current with industry developments, trends and regulations.
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA® (vibegron) 75 mg for Overactive Bladder at the Virtual 2021 Annual Meeting of the American Urological Association

Retrieved on: 
Friday, September 3, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, Allergy, Urology, Female, Vitamin, The Journal of Urology, Sumitomo Dainippon Pharma, Nausea, SUNY Downstate College of Medicine, Sore throat, PDT, Adult, Abstract (summary), European Union, Consideration of future consequences, Man, Clinical trial, FACS, Overactive bladder, Regulation of tobacco by the U.S. Food and Drug Administration, Diarrhea, Urinary retention, Kidney, Safety, Urinary tract infection, VideoRay UROVs, Center, NYSE, Faculty, Journal, Union, News, State university system, Headache, OAB, MMHC, Urinary incontinence, Digoxin, Liver, Tufts University School of Medicine, American Urological Association, Urologic disease, Breast milk, Doctor of Philosophy, FDA, Nasal congestion, Upper respiratory tract infection, State, Food, EVP, Pharmaceutical industry, Dietary supplement, Fine chemical, GEMTESA®, Urovant Sciences, GEMTESA®, UROVANT SCIENCES

The AUA21 virtual podium presentation will examine new clinical trial data on the effect of GEMTESA on ambulatory blood pressure in OAB patients.

Key Points: 
  • The AUA21 virtual podium presentation will examine new clinical trial data on the effect of GEMTESA on ambulatory blood pressure in OAB patients.
  • A separate virtual poster presentation will demonstrate its efficacy in patients with dry overactive bladder (without urinary leakage), based on a post-hoc analysis of data from the pivotal EMPOWUR study.
  • We believe that GEMTESA can help meet the needs of the estimated 30 million Americans who suffer from the bothersome symptoms of this condition.
  • This podium presentation will take place on Monday, September 13, during a virtual session from 1:00 to 3:00 p.m. PDT.

dPCR Market to Register $ 695.07mn growth during 2021-2025|Featuring Avance Biosciences Inc., Becton Dickinson and Co., and Bio-Rad Laboratories Inc. | 17000+ Technavio Reports

Retrieved on: 
Friday, August 27, 2021
CAGR, COVID-19, Genomics, USD, Consideration of future consequences, Healthcare industry, FREE, Animal

Key Considerations for Market Forecast:

Key Points: 
  • Key Considerations for Market Forecast:
    Related Report on Healthcare Industries:
    Genomics Market Report -The genomics market has the potential to grow by USD14.51 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 10.36%.
  • Gel Permeation Chromatography Market Report -The gel permeation chromatography market has the potential to grow by USD 455.30 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.38%.
  • Top 3 dPCR Market Players:
    If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
  • Get a report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown: